ベストプラクティス：進化する商用ゲノミクスIT情勢

目次

This IDC Health Insights report highlights the impending arrival of the $1,000 genome and its likely impact on transforming the life science industry forever. With a detailed view of leading trends as well as the current leading technology, IT, and informatics innovators supporting progress in this increasingly important space, we hope to provide readers with a snapshot of where we are and the likely players that will help drive future progress from both a general IT and an industry-specific vendor perspective. While much remains left to be learned, we are clearly on a path forward that should enable improved patient outcomes from a more personalized medicine-based future.

"While genomics may eventually be found to have only a supporting role in the manifestation of many human diseases, the advent of the age of genomics will still transform the life science and healthcare industries by accelerating progress in our understanding of human biology at the molecular level," says Alan S. Louie, research director, IDC Health Insights.

Table of Contents

IDC Health Insights Opinion

In This Study

Situation Overview

• Background

  • Democratization of Whole Genome Sequencing, with the Arrival of the $1,000 Genome

  • The Emerging Transformational Role for Genomics in the Life Sciences and Healthcare

  • The Impending Data Tsunami

  • Managing Commercial Genomics Efforts in the Enterprise

• Business Needs

• Management Challenges

The Best Practices

• Key IT Infrastructure

  • IT Hardware

  • IT Software

  • IT Services

    • FedEx

    • IT Cloud Solutions

  Specialized Infrastructure

  • Genomics Hardware

    • Illumina

    • Ion Torrent Systems (a Subsidiary of Life Technologies)

    • Oxford Nanopore Technologies

    • Pacific Biosciences of California

    • 454 Life Sciences (a Subsidiary of Roche Applied Science)

    • Bina Technologies

  • Genomics Software

    • Accelrys

    • Biomatters

    • CLC Bio

    • DNAnexus

    • Galaxy

    • GenomeQuest

    • Geospiza (a Subsidiary of PerkinElmer)

    • NextBio

    • Omixon - NGS Analysis Toolkit

    • Oracle Health Sciences Translational Research Center

    • SAS JMP Genomics

    • Strand Life Sciences

  • Genomics Services

    • BGI

    • Complete Genomics

    • Illumina

    • Tata Consultancy Services

    • Other Genomics Analysis Service Companies

Future Outlook

Essential Guidance

• Actions to Consider

  • Actions for Life Science Companies

  • Actions for Vendors

Learn More

• Related Research

• Synopsis

「ベストプラクティス：進化する商用ゲノミクスIT情勢」は2012年06月25日にヘルス・インダストリー・インサイツより発行されました。 当レポートはPages: 15で構成され、税抜￥540,000より販売しています。